Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 530
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
for
Rectal Adenocarcinoma, Stage I Rectal Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT02107105
Recruiting
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
for
Locally-Advanced Non-Small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07224152
Phase 1, Phase 2, Recruiting
Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06651593
Phase 2, Recruiting
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06959550
Phase 2, Recruiting
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
for
Advanced Intrahepatic Cholangiocarcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06858735
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants
for
Obesity-Related Malignant Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT04611087
Recruiting
Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
for
Metastatic Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05059678
Recruiting
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT05840484
Recruiting
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
for
Lymphedema, Fibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06494111
Phase 2, Recruiting
Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training
for
Malignant Vascular Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04832698
Recruiting
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 60+
Code: NCT06897488
Phase 2, Recruiting
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT05873192
Phase 2, Recruiting
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 25 - 70+
Code: NCT03408353
Recruiting
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
for
Diabetes, Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT06759701
Early Phase 1, Recruiting
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT06545604
Recruiting
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
for
Advanced Cholangiocarcinoma, FGFR2 Fusion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06439485
Phase 1, Phase 2, Recruiting
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
for
Thyroid Gland Medullary Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03892993
Recruiting
Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Ivonescimab, Clear Cell Renal Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06940518
Phase 2, Recruiting
Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer
for
Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07105033
Recruiting
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation